These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8181206)

  • 1. [Effect of the chronic treatment with L-acetylcarnitine in Down's syndrome].
    De Falco FA; D'Angelo E; Grimaldi G; Scafuro F; Sachez F; Caruso G
    Clin Ter; 1994 Feb; 144(2):123-7. PubMed ID: 8181206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of acetyl-L-carnitine administration on persons with Down syndrome.
    Pueschel SM
    Res Dev Disabil; 2006; 27(6):599-604. PubMed ID: 16621446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acetyl-L-carnitine in the treatment of mildly demented elderly patients.
    Passeri M; Cucinotta D; Bonati PA; Iannuccelli M; Parnetti L; Senin U
    Int J Clin Pharmacol Res; 1990; 10(1-2):75-9. PubMed ID: 2201659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mental impairment in aging: selection of patients, methods of evaluation and therapeutic possibilities of acetyl-L-carnitine.
    Passeri M; Iannuccelli M; Ciotti G; Bonati PA; Nolfe G; Cucinotta D
    Int J Clin Pharmacol Res; 1988; 8(5):367-76. PubMed ID: 3229874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of acetyl-L-carnitine in the treatment of cognitive deficit in chronic alcoholism.
    Tempesta E; Troncon R; Janiri L; Colusso L; Riscica P; Saraceni G; Gesmundo E; Calvani M; Benedetti N; Pola P
    Int J Clin Pharmacol Res; 1990; 10(1-2):101-7. PubMed ID: 2201652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [L-acetylcarnitine treatment on fragile X patients hyperactive behaviour].
    Calvani M; D'Iddio S; de Gaetano A; Mariotti P; Mosconi L; Pomponi MG; Tabolacci E; Torrioli MG; Vernacotola S; Neri G
    Rev Neurol; 2001 Oct; 33 Suppl 1():S65-70. PubMed ID: 12447823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Placebo-controlled double-blind randomized trial on the use of L-carnitine, L-acetylcarnitine, or combined L-carnitine and L-acetylcarnitine in men with idiopathic asthenozoospermia.
    Balercia G; Regoli F; Armeni T; Koverech A; Mantero F; Boscaro M
    Fertil Steril; 2005 Sep; 84(3):662-71. PubMed ID: 16169400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The aging of Down's Syndrome subjects].
    Fromage B; Anglade P
    Encephale; 2002; 28(3 Pt 1):212-6. PubMed ID: 12091781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative mortality in mentally retarded patients in California, with and without Down's syndrome, 1986-1991.
    Singer RB; Strauss D
    J Insur Med; 1997; 29(3):172-84. PubMed ID: 10176367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Verbal, visual, and spatio-sequential short-term memory: assessment of the storage capacities of children and teenagers with Down's syndrome.
    Frenkel S; Bourdin B
    J Intellect Disabil Res; 2009 Feb; 53(2):152-60. PubMed ID: 19077148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of the efficacy and tolerability of L-acetylcarnitine therapy in the senile brain.
    Bonavita E
    Int J Clin Pharmacol Ther Toxicol; 1986 Sep; 24(9):511-6. PubMed ID: 3781687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acetyl L-carnitine (ALC) treatment in elderly patients with fatigue.
    Malaguarnera M; Gargante MP; Cristaldi E; Colonna V; Messano M; Koverech A; Neri S; Vacante M; Cammalleri L; Motta M
    Arch Gerontol Geriatr; 2008; 46(2):181-90. PubMed ID: 17658628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risperidone use in children with Down syndrome, severe intellectual disability, and comorbid autistic spectrum disorders: a naturalistic study.
    Capone GT; Goyal P; Grados M; Smith B; Kammann H
    J Dev Behav Pediatr; 2008 Apr; 29(2):106-16. PubMed ID: 18349709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurophysiological studies of L-acetylcarnitine administration in man.
    Gambi D; Onofrj M; Calvani M; Faricelli A; Del Re ML; Bazzano S; Cutarella R; Fulgente T; Colangelo U
    Drugs Exp Clin Res; 1989; 15(9):435-46. PubMed ID: 2630254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the effects of acetyl L-carnitine and amantadine for the treatment of fatigue in multiple sclerosis: results of a pilot, randomised, double-blind, crossover trial.
    Tomassini V; Pozzilli C; Onesti E; Pasqualetti P; Marinelli F; Pisani A; Fieschi C
    J Neurol Sci; 2004 Mar; 218(1-2):103-8. PubMed ID: 14759641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double-blind, placebo-controlled study of L-acetylcarnitine for the treatment of hyperactive behavior in fragile X syndrome.
    Torrioli MG; Vernacotola S; Mariotti P; Bianchi E; Calvani M; De Gaetano A; Chiurazzi P; Neri G
    Am J Med Genet; 1999 Dec; 87(4):366-8. PubMed ID: 10588848
    [No Abstract]   [Full Text] [Related]  

  • 17. Acetyl-l-Carnitine in the treatment of anhedonia, melancholic and negative symptoms in alcohol dependent subjects.
    Martinotti G; Andreoli S; Reina D; Di Nicola M; Ortolani I; Tedeschi D; Fanella F; Pozzi G; Iannoni E; D'Iddio S; Prof LJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):953-8. PubMed ID: 21256179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of Down syndrome and other retarded children on the Cratty Gross-Motor Test.
    Henderson SE; Morris J; Ray S
    Am J Ment Defic; 1981 Jan; 85(4):416-24. PubMed ID: 6450535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Carnitine and Down's syndrome].
    Colombo ML; Girardo E; Gallo M; Ricci BM; Maina D
    Minerva Pediatr; 1989 Apr; 41(4):173-6. PubMed ID: 2528053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactive oxygen metabolites and prooxidant status in children with Down's syndrome.
    Carratelli M; Porcaro L; Ruscica M; De Simone E; Bertelli AA; Corsi MM
    Int J Clin Pharmacol Res; 2001; 21(2):79-84. PubMed ID: 11824651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.